Invitrogen

ApoER2 Monoclonal Antibody (13B2)

3个已发表图片

4 篇参考文献

查看其他12个LRP8抗体

抗体检测数据 (1)
已发表图片 (3)

ApoER2 Antibody in Western Blot (WB)

ApoER2 Antibody in Western Blot (WB)

图: 1 / 4

ApoER2 Antibody (MA5-36130) in WB

Western blot analysis of ApoER2 using a ApoER2 monoclonal antibody (Product #MA5-36130). Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody at a dilution of 1:500 was used in 5% BSA at room temperature for 2 hours. Goat Anti-Mouse IgG - HRP Secondary Antibody at 1:5,000 dilution was used for 1 hour at room temperature. Positive control: Lane 1: A549 cell lysate, Lane 2: SHSY5Y cell lysate, Lane 3: SKBR-3 cell lysate, Lane 4: U937 cell lysate

ApoER2 Antibody in Western Blot (WB)

ApoER2 Antibody in Immunocytochemistry, Immunohistochemistry, Immunohistochemistry (Paraffin) (ICC/IF, IHC, IHC (P))

ApoER2 Antibody in Western Blot (WB)

ApoER2 Antibody in Western Blot (WB)

Product Image Gallery

ApoER2 Antibody in Western Blot (WB) — Western blot analysis of ApoER2 using a ApoER2 monoclonal antibody (Product #MA5-36130). Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody at a dilution of 1:500 was used in 5% BSA at room temperature for 2 hours. Goat Anti-Mouse IgG - HRP Secondary Antibody at 1:5,000 dilution was used for 1 hour at room temperature. Positive control: Lane 1: A549 cell lysate, Lane 2: SHSY5Y cell lysate, Lane 3: SKBR-3 cell lysate, Lane 4: U937 cell lysate

ApoER2 Antibody in Immunocytochemistry, Immunohistochemistry, Immunohistochemistry (Paraffin) (ICC/IF, IHC, IHC (P)) — Fig. 5 LRP3 co-immunoprecipitates with apoE and APP. a Representative immunofluorescence photomicrograph showing LRP3 and ApoER2 labeling in the same cells in a hippocampus slice of a MA subject. Neurons (large cells) show LRP3 and ApoER2 co-localization; in addition, oligodendroglia-like cells (thin arrows) also co-localize both antibodies. b Representative western blots showing immunoprecipitation of LRP3 and co-immunoprecipitation of reelin (no immunoprecipitation), apoE, and APP, from non-demented (ND) and Alzheimer's disease (AD) extracts. T total input, B bound fraction, U unbound fraction, IPc bound fraction of the negative control

ApoER2 Antibody in Western Blot (WB) — Fig. 1 ApoER2/reelin signaling upregulates LRP3 expression. a qRT-PCR analysis showing expression of LRP3 mRNA and LDLR mRNA after transfection with GFP cDNA (control) and full-length ApoER2 cDNA (fApoER2) in SH-SYSH cells. 18S was used as an internal control for mRNA expression ( n = 10-12 for each condition, p < 0.001 for control versus fApoER2; t -test with Welch's correction). Note that the X axis begins at 50%. b Quantification and western blot showing the expression of full-length ApoER2, ApoER2-CTF, and LRP3 proteins after fApoER2 transfection and reelin (12 mug/ml) treatment for 24 h in SH-SY5Y cells. Tubulin was used as an internal control ( n = 9 for each condition, ** p < 0.001 for expression of fApoER2, t -test with Welch's correction, and ApoER2-CTF, t -test; * p < 0.05 for expression of LRP3, t -test). c Quantification and western blot showing the expression of LRP3 protein after reelin (12 mug/ml) treatment for 24 h or vehicle (Hanks's media) in neuro-differentiated SH-SY5Y cells with retinoic acid ( n = 9 for each condition, * p <0.05 t-test)

ApoER2 Antibody in Western Blot (WB) — Fig. 2 ApoER2-ICD increases LRP3 expression. a Representative western blot showing the expression of ApoER2-ICD after transfection with full-length ApoER2 cDNA (ApoER2) and reelin treatment (12mug/ml, ApoER2 + reelin) for 24 h in SH-SY5Y cells. For comparison, the expression of the ApoER2-ICD construct (ApoER2-ICD) is also shown. b Western blot and c quantification of LRP3 protein expression after ApoER2-ICD transfection in SH-SY5Y cells. Tubulin was used as an internal control ( n = 6 for each condition, * p < 0.001, t -test). d qRT-PCR analysis showing the expression of LRP3 mRNA ( n = 7 for each condition, * p < 0.05, t -test) and e LDLR mRNA ( n = 10 for each condition) after transfection with GFP cDNA (control) and ApoER2-ICD cDNA in SH-SY5Y cells. Note that the X axis in d begins at 50%. 18S was used as an internal control for mRNA expression

产品信息

MA5-36130

应用

建议稀释比

已发表文章

免疫印迹 (WB)

1:500

查看1篇已发表文章 1篇已发表文章

免疫组化 (IHC)

-

查看1篇已发表文章 1篇已发表文章

免疫组化（石蜡） (IHC (P))

-

查看1篇已发表文章 1篇已发表文章

免疫细胞化学 (ICC/IF)

-

查看1篇已发表文章 1篇已发表文章

产品规格

种属反应

Human

已发表种属

Human

宿主/亚型

Mouse / IgG2a

分类

Monoclonal

类型

Antibody

克隆号

13B2

抗原

Recombinant protein within Human APOER2 aa 47-275

查看免疫原

偶联物

Unconjugated Unconjugated Unconjugated

形式

Liquid

浓度

2 mg/mL

纯化类型

Protein A

保存液

PBS, pH 7.4, with 0.2% BSA, 50% glycerol

内含物

0.05% sodium azide

保存条件

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

运输条件

Ambient (domestic); Wet ice (international)

AB_2890275

靶标信息

Apolipoprotein E receptor 2 (ApoER2) is an NMDA associated protein found in neurons. It participates in important functions from guiding neurons in the embryonic brain to regulating synaptic signaling. It is also involved in debilitating neurodegenerative diseases such as schizophrenia and Alzheimer's disease.

仅用于科研。不用于诊断过程。未经明确授权不得转售。

Product References

The apolipoprotein receptor LRP3 compromises APP levels.

Alzheimer's research & therapy

Cuchillo-Ibañez I,Lennol MP,Escamilla S,Mata-Balaguer T,Valverde-Vozmediano L,Lopez-Font I,Ferrer I,Sáez-Valero J

MA5-36130 was used immunohistochemistry (paraffin) analyze LRP3 expression in middle-aged individuals (MA) and in cases with Alzheimer''s disease (AD)-related pathology, and the relation of LRP3 with APP.

Tue Nov 02 00:00:00 UTC 2021

The apolipoprotein receptor LRP3 compromises APP levels.

Alzheimer's research & therapy

Cuchillo-Ibañez I,Lennol MP,Escamilla S,Mata-Balaguer T,Valverde-Vozmediano L,Lopez-Font I,Ferrer I,Sáez-Valero J

MA5-36130 was used immunohistochemistry (paraffin) analyze LRP3 expression in middle-aged individuals (MA) and in cases with Alzheimer''s disease (AD)-related pathology, and the relation of LRP3 with APP.

Tue Nov 02 00:00:00 UTC 2021

The apolipoprotein receptor LRP3 compromises APP levels.

Alzheimer's research & therapy

Cuchillo-Ibañez I,Lennol MP,Escamilla S,Mata-Balaguer T,Valverde-Vozmediano L,Lopez-Font I,Ferrer I,Sáez-Valero J

MA5-36130 was used immunohistochemistry (paraffin) analyze LRP3 expression in middle-aged individuals (MA) and in cases with Alzheimer''s disease (AD)-related pathology, and the relation of LRP3 with APP.

Tue Nov 02 00:00:00 UTC 2021

The apolipoprotein receptor LRP3 compromises APP levels.

Alzheimer's research & therapy

Cuchillo-Ibañez I,Lennol MP,Escamilla S,Mata-Balaguer T,Valverde-Vozmediano L,Lopez-Font I,Ferrer I,Sáez-Valero J

MA5-36130 was used immunohistochemistry (paraffin) analyze LRP3 expression in middle-aged individuals (MA) and in cases with Alzheimer''s disease (AD)-related pathology, and the relation of LRP3 with APP.

Tue Nov 02 00:00:00 UTC 2021

The apolipoprotein receptor LRP3 compromises APP levels.

Alzheimer's research & therapy

Cuchillo-Ibañez I,Lennol MP,Escamilla S,Mata-Balaguer T,Valverde-Vozmediano L,Lopez-Font I,Ferrer I,Sáez-Valero J

MA5-36130 was used immunohistochemistry (paraffin) analyze LRP3 expression in middle-aged individuals (MA) and in cases with Alzheimer''s disease (AD)-related pathology, and the relation of LRP3 with APP.

Tue Nov 02 00:00:00 UTC 2021

生物信息学

蛋白别名: ApoE receptor 2; Apolipoprotein E receptor 2; low density lipoprotein receptor-related protein 8, apolipoprotein e receptor; Low-density lipoprotein receptor-related protein 8; LRP-8

查看更多收起

基因别名: APOER2; HSZ75190; LRP-8; LRP8; MCI1

查看更多收起

UniProt ID: (Human) Q14114

查看更多收起

Entrez Gene ID: (Human) 7804

查看更多收起

transmembrane signaling receptor activity low-density lipoprotein receptor activity calcium ion binding protein binding high-density lipoprotein particle binding kinesin binding very-low-density lipoprotein particle receptor activity apolipoprotein binding reelin receptor activity apolipoprotein

negative regulation of transcription from RNA polymerase II promoter retinoid metabolic process proteolysis lipid metabolic process endocytosis receptor-mediated endocytosis signal transduction cytokine-mediated signaling pathway ammon gyrus development cerebral cortex development positive regulation of CREB transcription factor activity reelin-mediated signaling pathway response to drug positive regulation of peptidyl-tyrosine phosphorylation modulation of synaptic transmission positive regulation of dendritic spine morphogenesis positive regulation of protein tyrosine kinase activity cellular response to growth factor stimulus cellular response to cholesterol positive regulation of dendrite development